Clinical trial
Gene Expression in Renal Transplant Patients With Field Actinic Keratosis Undergoing Metvix® PDT
NCT01000636 is registered in ClinicalTrials.gov with Galderma R&D as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Gene Expression in Renal Transplant Patients With Field Actinic Keratosis Undergoing Metvix® PDT
- Lead sponsor
- Galderma R&D
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 31, 2009
- Completion date
- October 31, 2011
- Enrollment
- 9 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
actinic keratosis